Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)
China
· Delayed Price · Currency is CNY 94.31
+3.79 (4.19%)
At close: Mar 10, 2026
SHE:301075 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Net Income | -125.32 | -62.67 | 18.85 | 20.5 | 68.51 | 91.99 | Upgrade
|
| Depreciation & Amortization | 29.16 | 29.26 | 18.91 | 15.77 | 14.81 | 12.13 | Upgrade
|
| Other Amortization | 0.58 | 0.47 | 0.38 | 1.13 | 1.12 | 1.12 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.04 | -0.04 | -0.08 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.26 | -0.26 | -0.05 | 3.07 | 1.45 | 1 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.33 | -5.33 | -5.65 | -0.3 | -0.18 | - | Upgrade
|
| Provision & Write-off of Bad Debts | 5.64 | 5.64 | 0.85 | - | - | - | Upgrade
|
| Other Operating Activities | 51.51 | -5.76 | -3.09 | -3.98 | -1.47 | -0.4 | Upgrade
|
| Change in Accounts Receivable | -32.38 | -32.38 | -12.99 | -4.87 | 6.57 | -21.07 | Upgrade
|
| Change in Inventory | -18.95 | -18.95 | 2.91 | -23.31 | 4.91 | -8.26 | Upgrade
|
| Change in Accounts Payable | 25.17 | 25.17 | -7.15 | -6.75 | -47.45 | -13.04 | Upgrade
|
| Operating Cash Flow | -72.55 | -67.18 | 12.41 | 1.13 | 48.15 | 63.64 | Upgrade
|
| Operating Cash Flow Growth | - | - | 1001.79% | -97.66% | -24.34% | 80.42% | Upgrade
|
| Capital Expenditures | -83.6 | -40.92 | -23.69 | -32.73 | -5.35 | -50.82 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0.57 | 0.01 | - | - | Upgrade
|
| Cash Acquisitions | -63.15 | -47.99 | -35.09 | - | - | - | Upgrade
|
| Divestitures | 60 | 60 | 0.54 | - | - | - | Upgrade
|
| Investment in Securities | -457.1 | -167.02 | -13.52 | -185 | - | - | Upgrade
|
| Other Investing Activities | 408.81 | 3.58 | 2.81 | 14.87 | -109.82 | - | Upgrade
|
| Investing Cash Flow | -135.04 | -192.35 | -68.38 | -202.84 | -115.16 | -50.82 | Upgrade
|
| Short-Term Debt Issued | - | 1.9 | - | - | 50 | 40 | Upgrade
|
| Long-Term Debt Issued | - | 167.81 | 230.1 | 100 | - | - | Upgrade
|
| Total Debt Issued | 171.01 | 169.71 | 230.1 | 100 | 50 | 40 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -20 | -65 | -40 | Upgrade
|
| Long-Term Debt Repaid | - | -111.72 | -168.57 | - | - | - | Upgrade
|
| Total Debt Repaid | -135.12 | -111.72 | -168.57 | -20 | -65 | -40 | Upgrade
|
| Net Debt Issued (Repaid) | 35.89 | 57.99 | 61.53 | 80 | -15 | - | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 507.8 | - | Upgrade
|
| Repurchase of Common Stock | -18.8 | -20.99 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -9.62 | -17.08 | -3.25 | -50.84 | -1.15 | -2.07 | Upgrade
|
| Other Financing Activities | 49.14 | 20.72 | 2.6 | 15.87 | -48.36 | -1.84 | Upgrade
|
| Financing Cash Flow | 56.61 | 40.64 | 60.87 | 45.04 | 443.29 | -3.91 | Upgrade
|
| Net Cash Flow | -150.98 | -218.88 | 4.91 | -156.68 | 376.28 | 8.9 | Upgrade
|
| Free Cash Flow | -156.15 | -108.09 | -11.28 | -31.6 | 42.8 | 12.82 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 233.99% | -43.28% | Upgrade
|
| Free Cash Flow Margin | -88.17% | -44.92% | -3.37% | -7.88% | 8.08% | 2.61% | Upgrade
|
| Free Cash Flow Per Share | -2.01 | -1.36 | -0.14 | -0.40 | 0.66 | 0.21 | Upgrade
|
| Cash Income Tax Paid | 9.96 | 17.8 | 38.3 | 39.32 | 67.14 | 62.36 | Upgrade
|
| Levered Free Cash Flow | 96.68 | -83.69 | -9.17 | -37.18 | 11.76 | -42.59 | Upgrade
|
| Unlevered Free Cash Flow | 98.94 | -78.75 | -7.22 | -36.33 | 12.5 | -41.35 | Upgrade
|
| Change in Working Capital | -28.49 | -28.49 | -17.7 | -35.06 | -36.09 | -42.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.